Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
Stimulation of collagen synthesis: GHK-Cu directly activates dermal fibroblasts, the cells responsible for collagen production
The review provides insights that contribute to future directions and drug discoveries for the treatment of RA
Without enough of these cells, your scalp doesn't get enough oxygen
In-use travel scenarios: A reconstituted vial or pen that you take out of the fridge for a 15-minute injection is fine
10 BenkhouchaM.Santiago-RaberM